Celine Dion has been diagnosed with rigid person syndrome, which is a rare neurological disorder. The 54-year-old singer announced, via Instagram, the cancellation of eight concerts that were to be held in Europe. But what is this disease? What symptoms does it cause? Is there a cure?
The Canadian said, “I’ve had health problems for a long time and it’s not easy for me to deal with. It’s sad to tell you that I won’t be ready to start my European tour again in February.” , In the social network🇧🇷
In early 2022, Celine Dion has already canceled 16 concerts that were scheduled in the US and Canada, as well as on her “Courage World Tour”, from March 9 to April 12. the case? He declared at the time “severe and persistent muscle spasms”.
What is rigid person syndrome?
It is a rare neurological disease that affects 1 in a million people. Most neurologists will encounter only one or two cases during their career. Currently, there is little data and it may take years for the disease to be diagnosed and treatment adapted. According to the National Institute of Neurological Disorders and Stroke, researchers are referring to an autoimmune reaction.
Celine Dion caused muscle spasms and affected some functions, such as movement and vocal cords. But this disease can also cause sensitivity to visual, acoustic and emotional stimuli. In a more advanced stage, it can cause chronic myalgia and persistent muscle stiffness. The spasms can be severe to the point of broken bones and other serious injuries.
First described by Moersch and Woltman in 1956, it is two to three times more common in women than in men. It appears, in most patients, between 20 and 50 years old.
Many patients with SPS also suffer from type 1 diabetes, anemia, and some types of cancer.
Is there a cure?
No, at present, there is no cure for this disease. However, analgesics or muscle relaxants are recommended to relieve symptoms and medications for anxiety, as they can lead to anxiety among patients.
Physiotherapy and occupational therapy are also recommended for movement loss.
Patients’ survival ranged from six to 28 years after the onset of symptoms.
